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Abstract
Background: Only 2% to 4% of patients with melanoma will be diagnosed with gastrointestinal
metastasis during the course of their disease. The most common sites of gastrointestinal
metastases from melanoma include the small bowel (35%–67%), colon (9%–15%) and stomach
(5%–7%), with a median survival of 6–10 months after surgery, and 18% survival at five years.
Metastatic melanoma to the gallbladder is extremely rare and it is associated with a very poor
prognosis.
Case presentation: We report a case of a 54-year old man presented to observation with
diagnosis of 6.1 mm thick, Clark's level IV, ulcerated melanoma of the trunk, developing in the
course of the disease metastatic involvement of the gallbladder as first site of recurrence, treated
by laparoscopic cholecystectomy. To date only few cases of patients with metastatic melanoma of
the gallbladder treated by this surgical procedure have been reported in literature.
Conclusion: Gallbladder metastasis represents a rare event as a first site of recurrence. It must
be considered a possible expression of systemic disease also despite radiological absence of other
metastatic lesions. Laparoscopic approach has a possible therapeutic role, but open surgery has
also a concomitant diagnostic purpose because gives the possibility of manual exploration of
abdominal cavity, useful particularly to reveal bowel metastatic lesions, not easily identifiable by
preoperative imaging examinations.
Background
Only 2% to 4% of patients with melanoma will be diag-
nosed with gastrointestinal (GI) metastasis during the
course of their disease [1]. The most common sites of GI
metastases from melanoma include the small bowel
(35%–67%), colon (9%–15%) and stomach (5%–7%),
with a median survival of 6–10 months after surgery, and
18% survival at five years [2].
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Metastatic melanoma to the gallbladder is extremely rare
and it is associated with a very poor prognosis [3]. We
report a case of patient with melanoma of the trunk devel-
oping in the course of the disease metastatic involvement
of the gallbladder as first site of recurrence, treated by
laparoscopic cholecystectomy. To date only few cases of
patients with metastatic melanoma of the gallbladder
treated by this surgical procedure have been reported in
literature [4-8].
Case presentation
In May 2001 a 54-year-old man presented to observation
with diagnosis of 6.1 mm thick, Clark's level IV, ulcerated
cutaneous melanoma of the trunk. Preoperative staging
with chest X-ray and abdominal ultrasound (US) did not
reveal signs of systemic disease. He underwent wide local
excision (WEX) and sentinel lymph node biopsy (SLNB).
Preoperative lymphoscintigraphy showed uptake of the
radiotracer in one node of the left axilla that was removed
and resulted on finally pathology negative for metastatic
melanoma. The patient was submitted to regular follow-
up every three months with physical examination, chest
X-ray, US and blood work, according to the Multicenter
Selective Lymphadenectomy Trial [9]. In January 2002
hepatobiliary US detected the presence of intracholecystic
nodule of 1.0 cm. Three months later the patient pre-
sented upper abdominal pain mimicking symptomatic
cholecystolithiasis. Blood analysis values were normal. US
examination showed an increasing in size to 2.0 cm of the
intracholecystic nodular image (Figure 1). Computerised
tomography (CT) confirmed the presence of a nodule in
the lumen of the gallbladder measuring about 2.0 cm and
a positron emission tomography (PET) revelead uptake in
the gallbladder area without evidence of systemic uptake
of the radiotracer. In May 2002 the patient underwent
laparoscopic cholecystectomy. Intrabdominal exploration
showed a normal gallbladder but with an enlarged blue
coloured lymph node along the cystic duct, and the pres-
ence of a dark spot image of the diaphragmatic perito-
neum. The gallbladder was removed together with the
lymph node along the cystic duct and put into an endobag
to avoid any contamination of the abdominal cavity and
extracted. An excisional biopsy of the diaphragmatic peri-
toneal lesion concluded the surgical procedure. Macro-
scopic evaluation of the gallbladder showed one vegetant
brown coloured polyp adherent to the mucosa, projected
into the lumen, measuring about 3,5 cm in size, and a
brown lymph node 1.5 cm in diameter. At histological
examination, the mucosal (Figure 2) and muscular layers
of the gallbladder were diffusely infiltrated by epithelioid
and spindle heavely pigmentated cells; the epithelium
was partially eroded and no junctional activity was evi-
dent; the cystic duct lymph node and the peritoneal node
were both involved by metastatic cells from melanoma.
Immunohistochemical staining of the removed tissues
showed a strong positivity for S 100 protein, HMB 45 and
MART-1 (Figure 3, 4, 5). Postoperative course was une-
ventful and the patient was discharged home on postop-
erative day two. No adjuvant chemotherapy was offered at
this time by our oncologists. Two months later the patient
presented clinical evidence of intestinal obstruction. CT
revealed intussusception of two segments of the small
bowel tract. At laparotomy resection of two portions of
the involved small bowel by two stenosing metastases
with contiguous involvement of the mesentery and of
mesenteric lymph nodes was performed. Pathology con-
firmed the abdominal recurrence by metastatic
Histological appereance of gallbladder intramucous infiltra- tion by melanoma cells stained with hematoxylin and eosin (×  100) Figure 2
Histological appereance of gallbladder intramucous infiltra-
tion by melanoma cells stained with hematoxylin and eosin (× 
100).
Ultrasound evidence of metastatic melanoma of the gallblad- der Figure 1
Ultrasound evidence of metastatic melanoma of the gallblad-
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melanoma. After surgery he recieved chemoimmuno-
therapy (fotemustine 100 mg/m2 and dacarbazine 900
mg/m2 intravenously every three weeks for a total of three
cycles plus interferon alfa-2b 5 MU/m2 subcutaneously).
Seventeen months after SLNB, PET showed disseminated
disease. The patient died shortly thereafter in April 2003,
eleven months after cholecystectomy.
Discussion
Both primary and metastatic melanoma of the gallbladder
is extremely rare. The distinction between primary and
metastatic lesions can be complicated on the basis of clin-
ical, radiological and histopathological features, however
the presence of a past history of melanoma in the skin or
in other common primary sites combined with the
absence of junctional activity (intra-epithelial extension
in the mucosa overlying the tumor) orientate to the diag-
nosis of metastatic lesion, even if some investigators also
described junctional activity in cases of metastatic
involvement of the gallbladder, not considering this phe-
nomenon sufficient to distinguish between primary and
metastatic disease [10]. Moreover some authors believe
that melanoma in the biliary tract is almost always a
metastasis and the majority of cases described as primary
are secondary to an unrecognized or regressed extrabiliary
site [11-15].
Although clinically rare, melanoma metastatic to the gall-
bladder accounts for 30–60% of all metastatic lesions
involved this site [16]. Most of patients with gallbladder
metastasis are described to have widespread disease at
time of diagnosis; only few patients had a first metastasis
limited to the gallbladder [17]. Isolated metastatic disease
to the biliary system is accompanied by obstructive jaun-
dice if the tumor is located in the common bile duct or by
upper abdominal pain mimicking symptomatic cholecys-
tolithiasis, but asymptomatic cases were also described
[4]. In contrast to gallbladder cancer, melanoma of the
gallbladder does not seem associated to cholelithiasis
[17].
Neoplastic cells immunostained with anti-MART-1 antibodies  (× 400) Figure 5
Neoplastic cells immunostained with anti-MART-1 antibodies 
(× 400).
Neoplastic cells immunostained with anti-S-100 antibodies (×  400) Figure 3
Neoplastic cells immunostained with anti-S-100 antibodies (× 
400).
Neoplastic cells immunostained with anti-HMB-45 antibodies  (× 400) Figure 4
Neoplastic cells immunostained with anti-HMB-45 antibodies 
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Because of the extreme rarity of gallbladder melanoma,
the diagnosis is difficult to suspect preoperatively. Never-
theless accurate investigation of unclear lesions of the
gallbladder and biliary tree in patients with a past history
of melanoma will be necessary [3]. Ultrasonography is the
staging investigation which can revealed an intrachole-
cystic nodule or mass preoperatively. Metastatic disease
can appear as multiple flat and infiltrative lesions or as
single polypoid tumor [18]. In the latter case, ultrasound
appereances typical of gallbladder metastases are those of
single or multiple hyperechoic masses increasing in size
more than 1 cm in diameter and attached to the gallblad-
der wall, with minimal to absent acoustic shadowing due
to their low density, and with dopplergraphic signs of
blood flow [19-21]. CT scan can reveal solid masses of the
biliary tract and a positivity at FDG PET can reveal meta-
static unespected sites [17,7].
The prognosis of melanoma of the gallbladder is very
poor. The mean survival rate for patients with primary and
metastatic lesions is 20.1 months and 8.4 months respec-
tively [10]. Because of the rarity of the primary melano-
mas of the gallbladder, no therapeutic guidelines can be
recommended. Nevertheless, aggressive surgical therapy
appears, in part, to prolong survival, and to improve the
quality of life in several patients [22].
In case of metastatic lesions of the gallbladder, treatment
options depend on the extension of the disease and on the
clinical status of the patient. When metastases are limited
to the gallbladder, surgical treatment is indicated to avoid
symptoms or tumor complications and can improve prog-
nosis significantly [5,10]. Dong et al reported a 100% sur-
vival at 1 year in patients who underwent surgery for
isolated gallbladder metastases compared with 0% for
those with unresectable tumors. In this series, among 19
patients with melanoma metastatic to the gallbladder, the
median survival following presentation with disease was
7 months, with the majority of patients having multiple
metastases (89%) and only 2 patients with disease con-
fined to the gallbladder that survived more than 100
months [17]. Nevertheless, even in case of disseminated
disease, surgical removal seems to be a worthwile pallia-
tive procedure [10,13].
The effectiveness of complementary chemotherapy and
immunotherapy after removal of a metastasis of malig-
nant melanoma of the gastrointestinal tract is still being
examined [4]. In the case we reported, after preoperative
imaging examinations and laparoscopic surgery our
oncologists considered the patient free of disease, there-
fore no adjuvant chemotherapy was offered at this time, as
usually done after surgery in absence of residual meta-
static disease. After the second operation they take in con-
sideration to administer chemoimmunotherapy as a
palliative procedure for the disease progression.
Chemotherapy remains a palliative procedure for patients
with stage IV melanoma and even if can improve disease
free survival, does not influence 5-year overall survival
rate, that in these patients is approximately 5% [23].
In the majority of cases patients with primary or second-
ary melanomas to the gallbladder were treated by conven-
tional surgery. Few cases of laparoscopic cholecystectomy
have been described in literature as treatment of
melanoma to the gallbladder, and it is unclear when this
surgical management is adequate.
Velez et al reported a case of patient with primary
melanoma of the gallbladder that was removed laparo-
scopically, but the diagnosis was made only after his-
topathological examination. The patient remained disease
free at last follow-up reported of 9 months after surgery
[22].
Seelig et al described a case of isolated involvement of the
gallbladder by metastatic melanoma. Even if visceral
involvement is a sign of general metastasis, in this case
there was no sign of any further metastasis, so the cole-
cysthectomy was conducted laparoscopically with partic-
ular attention to take the gallbladder into an endobag
before extraction via the periumbilical incision, in order
to prevent any metastatic deposition. The patient
remained disease free at last follow-up reported, 20
months after surgery [4]. Kohler et al reported two patients
undergoing laparoscopic cholecystectomy in isolated
metastasis of malignant melanoma to the gallbladder.
They affirm that since the vast majority of melanoma
metastases of the gallbladder are located intraluminally
and lymphadenectomy in the region of the hepatoduode-
nal ligament does not appear to be appropriate, the oper-
ation should be carried out laparoscopically [5]. Kats et al
reported 13 patients with a diagnosis of melanoma meta-
static to the gallbladder. In this series three cholecystecto-
mies were performed laparoscopically, with two instances
of subsequent port site recurrence, even if the specimens
were placed into retrieval bags prior to removal through
the port sites. Five patients presented with isolated gall-
bladder metastases while 8 presented with disease at mul-
tiple sites. From the time of metastatic gallbladder
involvement, the median survival was 12 months, with 1
patient surviving 12 years after treatment and 8 patients
surviving for 1 year or more. Patients who presented with
disease confined to the gallbladder had a median survival
of 39 months compared to a median survival of 10
months for patients presenting with multiple metastatic
sites, and among patients who underwent cholecystec-
tomy, the median survival following treatment was 16World Journal of Surgical Oncology 2007, 5:141 http://www.wjso.com/content/5/1/141
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months, compared to 6 months for those managed not
operatively. They concluded that although most patients
with metastatic melanoma are not candidates for curative
resection and suffer from a poor prognosis, proper selec-
tion of patients is imperative for palliative procedures. In
case of metastatic gallbladder melanoma, symptomatic
patients and those with melanoma confined to the gall-
bladder are among those who are most likely to benefit
from cholecystectomy. Due to the aggressive nature and
biology of advanced melanoma, minimally invasive
cholecystectomy seems to be an adequate surgical option
[8]. Tuveri et al reported a case of a patient with an isolated
metastatic melanoma to the gallbladder treated by a lapar-
oscopic cholecystectomy and lymphadenectomy of the
hepatoduodenal ligament. The authors emphasize the
appropiateness of a laparoscopic approach in this kind of
patients, once ruled out the presence of widespread dis-
ease, with a curative intent and adequate palliation of
symptoms. The patient remained free of disease at last fol-
low-up reported of 5 years [24].
From 1996 to 2006 at the National Cancer Institute of
Naples 1684 patients with diagnosis of cutaneous
melanoma were surgically treated. Of these, 30 (1.7%)
developed metastatic lesions to the GI tract liable to surgi-
cal exploration. Only one patient developed a gallbladder
metastasis as first site of recurrence.
In the case we presented, there was no preoperatively con-
firmation of metastatic involvement of the gallbladder. At
beginning of the operation despite a very small peritoneal
nodule on the diaphragmatic cupola, there was not other
evidence of disseminated disease including the normal
aspect of the gallbladder. Cholecystectomy was conducted
without particular difficulties, as a lythiasis operation, and
the removal of the enlarged lymph node along cystic duct
did not appear complicated. We utilized an endobag to
remove the resected specimens. This precaution together
with gentle manipulation of the gallbladder and avoid-
ance of perforation should be practiced to help minimize
the possibility of tumor seeding during laparoscopic sur-
gery, responsible for port site metastases or peritoneal
metastases [24]. No complications were recorded periop-
eratively and in the course of the disease that might be cor-
related to the laparoscopic approach adopted. The only
controversial issue of the laparoscopic approach was its
diagnostic purpose in absence of radiological evidence of
systemic disease, because of the impossibility of a manual
exploration of the bowel tract as we routinely performed
at laparotomy to detect intraluminal metastatic lesions
involving the mucosa, not easily identifiable preopera-
tively by instrumental examinations, despite of those in
form of multiple serosal implants, more easily identified
[23]. Anyway, metastatic lesions of the bowel may missed
at manual exploration as well.
Conclusion
Melanoma has a propensity to spread extensively, often
involving multiple visceral sites. Biliary symptoms in a
patient with a history of cutaneous melanoma should be
investigated as possible evidence of biliary tract metas-
tases. Gallbladder metastasis represents a rare event as first
site of recurrence as occurred in the case reported in this
paper. It must be considered a possible expression of sys-
temic disease also despite radiological (CT or PET)
absence of other metastatic lesions. Laparoscopic
approach has a possible therapeutic role, expecially in
patients with isolated metastasis of the gallbladder, but
open surgery has also a concomitant diagnostic purpose
because gives the possibility of manual exploration of the
abdominal cavity, useful particularly to reveal bowel met-
astatic lesions, not easily identifiable by preoperative
imaging examinations.
In absence of adjuvant therapy the surgical approach is
the only treatment that may assure a better survival.
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